DOCSLIB.ORG

DB Abs Cagliari Cong SIF 2007

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
DB Abs Cagliari Cong SIF 2007 33° Congresso Nazionale della SIF - Cagliari 6-9 giugno 2007 - Raccolta abstracts TOTALE ABSTRACTS VALIDI: 828 Ultimo aggiornamento: (167 simposi + 100 orali + 561 posters) 24-mag-07 Cod Autore (primo nome) Titolo abs Esp. Tema Data (N°) cognome-nome (titolo completo) O/P/I 1 Carnini Chiara CYSTEINYL LEUKOTRIENES IN HUMAN ENDOTHELIAL CELLS: SYNTHPEoSstIeSr AND ACTIVI1T6IES 07-giu 2 Ghelardini Carla ANTIHYPERALGESIC EFFECTS OF THE PYRROLIDINONE DERIVATIVEO rNaIlKe-13317 IN MdoOloDrEeLS OF N0E7-UgRiuOPATHIC PAIN 3 Cuzzocrea Salvatore PARG ACTIVITY MEDIATES POST-TRAUMATIC INFLAMMATORY REACOTrIaOleN AFTER EXnPeuErRoIMENTA0L9 S-gPiuINAL CORD TRAUMA 4 Cuzzocrea Salvatore ESTROGEN RECEPTOR ANTAGONIST ICI 182,780 INHIBITS THE ANTPI-IoNsFteLrAMMATORY1 E6FFECT OF07 G-gLiUu COCORTICOIDS 5 Cuzzocrea Salvatore GLYCOGEN SYNTHASE KINASE-3 INHIBITION ATTENUATES THE DEPVoEsLtOerPMENT OF B1L2EOMYCIN0-8IN-gDiuUCED LUNG INJURY 6 De sarro Angelina PROTECTIVE EFFECT OF HYPERICUM PERFORATUM IN ZYMOSAN-IPNoDsUteCrED MULTIPL2E2 ORGAN D08Y-SgFiuUNCTION SYNDROME 7 De sarro Angelina ROLE OF PEROXISOME PROLIFERATORS ACTIVATED RECEPTORS PAoLPstHeAr (PPAR- ) IN1 6ACUTE PA0N8C-gRiuEATITIS INDUCED BY CERULEIN 8 Esposito Emanuela GENETIC OR PHARMACOLOGICAL INHIBITION OF TNF- REDUCED SPOLrAalNeCHNIC ISCgHioEvaMnIiA AND R07E-PgEiuRFUSION INJURY 9 Martire Maria SELECTIVE REGULATION OF [3H]D-ASPARTATE RELEASE FROM HIPPPoOsCteArMPAL NERV4E ENDINGS07 B-gYi uLARGE-CONDUCTANCE CA2+- AND VOLTAGE-ACTIVATED K+ (BK) CHANNELS 10 Mey Valentina SYNERGISTIC CYTOTOXICITY AND PHARMACOGENETICS OF GEMCPIToAsBteINr E AND ZD614774 IN BLAD07D-EgiRu CANCER CELL LINES 11 Nannizzi Sara SYNERGISTIC CYTOTOXICITY OF OXALIPLATIN AND PEMETREXED IPNo CstOeLr ON CANCE2R3 CELLS: C0E8L-LgUiuLAR AND MOLECULAR MECHANISMS 12 Ricciardi Simona SYNERGISTIC CYTOTOXICITY, INHIBITION OF AKT AND C-KIT PHOSPPHosOtRerYLATION, MO17DULATION0 7O-gFi uGENE EXPRESSION BY SORAFENIB AND GEMCITABINE IN HUMAN PANCREATIC CANCER CELLS 13 Giovannetti Elisa MOLECULAR MECHANISMS UNDERLYING THE SYNERGISTIC INTERAPCosTtIeOrN OF THE E2G3FR TYROS08IN-gEiu KINASE INHIBITOR ERLOTINIB WITH THE MULTITARGETED ANTIFOLATE PEMETREXED IN NON-SMALL CELL LUNG CANCER CELLS 14 Gardoni Fabrizio NEW TARGETS FOR PHARMACOLOGICAL INTERVENTION IN THE GLOUrTaAleMATERGIC nSeYuNroAPSE 09-giu 15 Amatori Federica M PHARMACOGENETIC EVALUATION OF AURORA A KINASE IN COLORPEoCsTteArL CANCERS23 08-giu 16 Fioravanti Anna ANTIANGIOGENIC AND ANTITUMOUR EFFECTS OF METRONOMIC IRPINosOtTeEr CAN (CPT-131) 07-giu 17 Lastella Marianna OLYMORPHISMS OF THE ABCB1 GENE PREDICT DRUG RESISTANCEP oINs tEerPILEPTIC PA2T3IENTS 08-giu 18 Colucci Rocchina EFFECTS OF CYCLOOXYGENASE INHIBITORS ON MOLECULAR MECPHoAsNteISr MS IMPLICA13TED IN GA0S7T-gRiIuC ULCER HEALING 19 Ghisu Narcisa SEROTONIN TRANSPORTER 5HTTLPR POLYMORPHISM, CLINICAL VPAoRsItAeNrTS AND SY2M3PTOM SE0V7E-RgiIuTY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME 20 Fornai Matteo ROLE OF A2A ADENOSINE RECEPTORS IN THE REGULATION OF HUPMoAsNte Cr OLON MOT1I3LITY 08-giu 21 Antonioli Luca APP, A NOVEL SELECTIVE ADENOSINE DEAMINASE INHIBITOR, IS EFPFoEstCeTrIVE AGAINS1T3 EXPERIM0E8N-gTiuAL COLITIS 22 Rizzo Valerio EFFECTS OF NITRIC OXIDE INFLUENCE ON EXPERIMENTALLY-INDUPCoEsDte Hr YPEREXCIT7ABILITY OF0 7T-HgiEu HIPPOCAMPUS: IN VIVO AND IN VITRO COMPARATIVE ELECTROPHYSIOLOGICAL STUDY IN THE RAT 23 Sanguedolce Rosario ANALYSIS OF THE THYMIDYLATE SYNTHASE GENE STRUCTURE IN PCoOsLtOerRECTAL CA1N7CER PATI0E8N-TgiSu, AND ITS POSSIBLE RELATION WITH THE 5-FLUOROURACIL DRUG RESPONSE 24 Vivoli Elisa ROLE OF THE TYPE 2 AND 3 INOSITOL 1,4,5-TRISPHOSPHATE RECEPPoTsOteRr IN MUSCAR9INIC ANTIN0O7-CgiIuCEPTION IN MICE 25 Norcini Monica INVOLVEMENT OF TYPE 1 AND 3 RYANODINE RECEPTOR IN MOUSEP oMsUteSrCARINIC AN9TINOCICEP0T7I-OgiNu 26 Maggio Roberto THERAPEUTICAL IMPLICATIONS OF INTRAMEMBRANE Simp 27 Di Paolo Antonello 5-FLUOROURACIL EXPOSURE PREDICTS DISEASE-FREE SURVIVAL Orale antitumor 08-giu 28 Montuschi Paolo NONINVASIVE METHODS FOR MONITORING AIRWAY INFLAMMATIONS IiNm pCHRONIC OBSTRUCTIVE PULMONARY DISEASE 29 Barnes Peter NEW PHARMACOLOGICAL STRATEGIES FOR COPD Simp 30 Vasina Valentina EFFECTS OF THE NON-PEPTIDYL LOW MOLECULAR WEIGHT RADICPAoLs SteCrAVENGER I1A3C IN DNBS0-8IN-gDiuUCED COLITIS IN RATS 31 Citraro Rita DIFFERENT ROLE OF NMDA RECEPTORS IN THE ROSTRAL AND CAUPDosAtLe rPART OF TH7ALAMIC RE0T7I-CgUiuLAR NUCLEUS IN A RAT MODEL OF ABSENCE EPILEPSY, THE WAG/RIJ RAT 32 Ferreri Ibbadu Guido HOMOCYSTEINE INDUCED AN INCREASE OF ABSENCE SEIZURES INP oTsHtEer ELECTROCO7GRAPHIC 0P7A-gTiTuERN OF WAG/RIJ RAT 33 Russo Emilio TOPIRAMATE DOSE-DEPENDENTLY MODIFIES SLOW INHIBITORY POPoSsTt eSrYNAPTIC PO7TENTIALS 0E7V-gOiuKED IN RAT OLFACTORY CORTICAL NEURONES IN VITRO 34 Donato Giuseppe APOMORPHINE-INDUCED NEURODEGENERATION IN MONGOLIAN GPEoRsBteILr HIPPOCAMP8US 08-giu 35 Comelli Francesca ANTIHYPERALGESIC EFFECT OF A CANNABIS SATIVA EXTRACT IN AO RraAlTe MODEL OsFc iNenEzUeROPAT0H9I-Cg iuPAIN: MECHANISMS INVOLVED 36 Amadio Susanna P2 RECEPTORS: NEW TRENDS IN THE CENTRAL NERVOUS SYSTEMSimp 37 Simioni Carolina HYPOXIA INHIBITS PACLITAXEL-INDUCED APOPTOSIS THROUGH ADOErNaOleSINE giovani 07-giu 38 Fogli Eleonora BINDING THERMODYNAMICS AT THE HUMAN A2B ADENOSINE RECEPPoTsOteRr 1 08-giu 39 Gessi Stefania ADENOSINE RECEPTORS IN COLON CARCINOMA TISSUES AND COLOOrNa lTeUMORAL sCcEieLnLz LeINES: F0O9-CgUiuS ON THE A3 ADENOSINE SUBTYPE 40 Sacchetto Valeria ADENOSINE MODULATES VASCULAR ENDOTHELIAL GROWTH FACTPOoRs tEerXPRESSION 1VIA HYPOX0I8A--gINiuDUCIBLE FACTOR-1 IN HUMAN GLIOBLASTOMA CELLS 41 Pizza Vincenzo INSERTION/DELETION POLYMORPHISM OF THE ANGIOTENSIN I-CONPVosEtReTr ING ENZYM9E GENE IN0 8M-gIGiuRAINE PATIENTS 42 Cammarano Michela LIFESTYLE INTERVENTIONS ON BODYWEIGHT GAIN OLANZAPINE-IPNoDsUteCrED: RESULT7 FROM A R0A8N-gDiuOMIZED-CONTROLLED TRIAL 43 Raffa Robert FLUMAZENIL-SENSITIVE DOSE-RELATED PHYSICAL DEPENDENCE IPNo PsLteArNARIANS PR7ODUCED B0Y7 -TgWiu O BENZODIAZEPINE AND ONE NON-BENZODIAZEPINE BENZODIAZEPINE RECEPTOR AGONISTS 44 Pizza Vincenzo GENETIC POLYMORPHISMS AND MIGRAINE Poster 9 08-giu 45 Milano Walter DISTURBANCES OF EATING BEHAVIOR DURING WORKPLACE SUFFPEoRsINteGr 10 07-giu 46 Milano Walter TREATMENT OF PREMENSTRUAL SYNDROME WITH CONTINUOUS LPOoWst eDrOSAGE SER7TRALIN 08-giu 47 Rocchitta Gaia DEVELOPMENT OF A NEW BIOTELEMETRY SYSTEM FOR REAL-TIMEO MraOleNITORING gOioFv NanITi RIC OX0I7D-Egi,u GLUTAMATE AND ASCORBIC ACID IN THE STRIATUM OF FREELY MOVING RATS 48 Serra Pier Andrea DOPAMINE AND L-DOPA INCREASE IN VITRO PROLIFERATION OF STPEoMst eCrELLS FROM 3THE MOUS0E7 -SgiUuBVENTRICULAR ZONE 49 Manca Antonio EFFECTS OF SYSTEMIC MPTP ADMINISTRATION ON BEHAVIOR ANDP oDsOtePrAMINE CHA1N0GES IN DI0A7L-YgiSuATE FROM THE STRIATUM OF FREELY MOVING MICE 51 Luccarini Ilaria ATORVASTATIN AND MINOCYCLINE, EFFECTIVE COMBINATION IN EPXoPsEtRerIMENTAL AU1T8OIMMUNE0 8E-NgiCuEPHALOMYELITIS 52 Ciceroni Cinzia ACTIVATION OF GROUP II METABOTROPIC GLUTAMATE RECEPTORPSo PstReErVENTS THE1 DIFFEREN0T7I-AgTiuION OF CULTURED NEURAL PROGENITOR CELLS ISOLATED FROM THE MOUSE SUBVENTRICULAR ZONE INTO MATURE ASTROCYTES 53 Cappuccio Irene INDIVIDUAL SUBTYPES OF METABOTROPIC GLUTAMATE RECEPTORPSos tReErGULATES N1EURAL DIF0F7E-gRiuENTIATION OF CULTURED MOUSE EMBRYONIC STEM CELLS 54 Sticozzi Claudia ROLE OF NO/Ca2+/CaM/MAPK SIGNALLING PATHWAY IN THE MITOGPEoNsItCe rEFFECT OF 3IL-1 IN C6 0G7L-IgOiuMA CELLS 55 Spinsanti Paola OPPOSITE EFFECTS ON CELL PROLIFERATION BY WNT1 AND WNT7PAo sPtRerOTEINS IN C1ULTURED P07C-1g2iu CELLS 56 Aviello Gabriella A SYSTEMATIC REVIEW ON THE EFFICACY AND SAFETY OF CIMICIFOUGraAle RACEMOSgAenere 08-giu 57 Baraldi Piergiovanni NEW AGONISTS AND ANTAGONISTS OF THE A2B ADENOSINE Simp 58 Serra Pier Andrea THE IN VITRO ASCORBIC ACID/DEHYDROASCORBIC ACID CYCLE IN OSTraElMe CELLS FRnOeuMro THE MO0U9S-gEi uSUBVENTRICULAR ZONE 59 Melchiorri Daniela METABOTROPIC GLUTAMATE RECEPTORS BEYOND THE REGULATIOSiNm OpF SYNAPTIC PLASTICITY: A ROLE IN THE PROLIFERATION AND DIFFERENTIATION OF STEM/PROGENITOR CELLS 60 Zani Alessia INCREASED TOXICITY OF COCAINE ADULTERATED WITH ATROPINEP:o EsFteFrICACY OF D1IA1ZEPAM 07-giu 61 Pozzesi Nicola IL-2 INDUCES AN ALTERED CD4/CD8 RATIO OF SPLENIC T LYMPHOCPYoTsEteSr FROM TRA1N8SGENIC M0I8C-Egi uOVEREXPRESSING THE GLUCOCORTICOID-INDUCED PROTEIN GILZ 62 De Filippis Daniele MELATONIN REVERSES LPS-INDUCED GASTRO-INTESTINAL MOTILIPToYs DteISr TURBANCE1S3 THROUG0H7 -TgHiuE INHIBITION OF OXIDATIVE STRESS 63 La Rana Giovanna PPAR-? AGONISTS CAUSE ANALGESIA THROUGH IKca AND BKca POOTAraSleSIUM CHANdNoEloLrSe ACTIVA0T7-IOgiuN 64 Varani Katia ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHROSNiImCp OBSTRUCTIVE PULMONARY DISEASE 65 Vincenzi Fabrizio M3 MUSCARINIC RECEPTORS IN PERIPHERAL LUNG PARENCHIMA OPFo sPteArTIENTS WIT1H2 CHRONIC0 8O-gBiSuTRUCTIVE PULMONARY DISEASE 66 Tosi Alice PHARMACOLOGICAL CHARACTERIZATION OF ADENOSINE RECEPTOPoRsSt eINr BOVINE CH1ONDROCY0T8E-gSiu 67 D'Acunto Cosimo EFFECTS OF A NOVEL HDAC INHIBITOR FR235222 IN THE HUMAN PROOrMalOe NOCYTICan CtitEuLmLo LrINE U90387-g: iRu OLE OF ANNEXIN A1 68 Bizzarro Valentina EXPRESSION OF ANNEXIN A1 IN MOUSE MYOBLAST DIFFERENTIATPIOoNs tCerELL LINE 3 07-giu 69 Musazzi Laura FUNCTIONAL PROTEOMICS OF NEUROPLASTICITY-RELATED SIGNAPLoINsGte rIN A RAT MO4DEL OF DE0P8R-gEiuSSION WITH GENE-ENVIROMENT INTERACTION 70 Sasso Oscar REPEATED TREATMENT WITH AM404 REDUCES MECHANICAL ALLOPDoYsNteIAr AND THERM9 AL HYPER0A8-LgGiuESIA IN A MODEL OF NEUROPATHIC PAIN WITHOUT CENTRAL EFFECTS 71 Valsecchi Anna PHYTOESTROGEN GENISTEIN REDUCES NOCICEPTIVE HYPERSENSPIoTsIVteITr
Load more

Recommended publications
  • 615 Neuroscience-Cayman-Bertin
    Thomas G. Brock, Ph.D. Introduction to Neuroscience In our first Biology classes, we learned that lipids form the membranes around cells. For many students, interests quickly moved to the intracellular constituents ‘that really matter’, or to how cells or systems work in health and disease. If there was further thought about lipids, it might have been limited to more personal issues, like an expanding waistline. It was easy to forget about lipids in the complexities of, say, Alzheimer’s Disease, where tau protein is hyperphosphorylated by a host of kinases before forming neurofibrillary tangles and amyloid precursor protein is processed by assorted secretases, ultimately aggregating to form neurodegenerating plaques. What possible role could lipids have in all this? After all, lipids just form the membranes around cells. Fortunately, neuroscientists study complex systems. Whether working at the molecular, cellular, or organismal level, the research focus always returns to the intricately interconnected bigger picture. Perhaps surprisingly, lipids keep emerging as part of the bigger picture. At least, the smaller lipids do. Many of the smaller lipids, including the cannabinoids and eicosanoids, act as paracrine hormones, modulating cell functions in a receptor-mediated fashion. In this sense, they are rather like the peptide hormones in their diversity and actions. In the neurosystem, this means that these signaling lipids determine if synapses fire or not, when cells differentiate or die, and whether tissues remain healthy or become inflamed. Returning to the question posed above about lipids in Alzheimer’s, these mediators have roles at many levels in the course of the disease, as presented in an article on page 42 of this catalog.
    [Show full text]
  • Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer
    cancers Review Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer Viktoriia Cherkasova, Olga Kovalchuk * and Igor Kovalchuk * Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 7X8, Canada; [email protected] * Correspondence: [email protected] (O.K.); [email protected] (I.K.) Simple Summary: In recent years, multiple preclinical studies have shown that changes in endo- cannabinoid system signaling may have various effects on intestinal inflammation and colorectal cancer. However, not all tumors can respond to cannabinoid therapy in the same manner. Given that colorectal cancer is a heterogeneous disease with different genomic landscapes, experiments with cannabinoids should involve different molecular subtypes, emerging mutations, and various stages of the disease. We hope that this review can help researchers form a comprehensive understanding of cannabinoid interactions in colorectal cancer and intestinal bowel diseases. We believe that selecting a particular experimental model based on the disease’s genetic landscape is a crucial step in the drug discovery, which eventually may tremendously benefit patient’s treatment outcomes and bring us one step closer to individualized medicine. Abstract: Despite the multiple preventive measures and treatment options, colorectal cancer holds a significant place in the world’s disease and mortality rates. The development of novel therapy is in Citation: Cherkasova, V.; Kovalchuk, critical need, and based on recent experimental data, cannabinoids could become excellent candidates. O.; Kovalchuk, I. Cannabinoids and This review covered known experimental studies regarding the effects of cannabinoids on intestinal Endocannabinoid System Changes in inflammation and colorectal cancer. In our opinion, because colorectal cancer is a heterogeneous Intestinal Inflammation and disease with different genomic landscapes, the choice of cannabinoids for tumor prevention and Colorectal Cancer.
    [Show full text]
  • N-Acyl-Dopamines: Novel Synthetic CB1 Cannabinoid-Receptor Ligands
    Biochem. J. (2000) 351, 817–824 (Printed in Great Britain) 817 N-acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo Tiziana BISOGNO*, Dominique MELCK*, Mikhail Yu. BOBROV†, Natalia M. GRETSKAYA†, Vladimir V. BEZUGLOV†, Luciano DE PETROCELLIS‡ and Vincenzo DI MARZO*1 *Istituto per la Chimica di Molecole di Interesse Biologico, C.N.R., Via Toiano 6, 80072 Arco Felice, Napoli, Italy, †Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, R. A. S., 16/10 Miklukho-Maklaya Str., 117871 Moscow GSP7, Russia, and ‡Istituto di Cibernetica, C.N.R., Via Toiano 6, 80072 Arco Felice, Napoli, Italy We reported previously that synthetic amides of polyunsaturated selectivity for the anandamide transporter over FAAH. AA-DA fatty acids with bioactive amines can result in substances that (0.1–10 µM) did not displace D1 and D2 dopamine-receptor interact with proteins of the endogenous cannabinoid system high-affinity ligands from rat brain membranes, thus suggesting (ECS). Here we synthesized a series of N-acyl-dopamines that this compound has little affinity for these receptors. AA-DA (NADAs) and studied their effects on the anandamide membrane was more potent and efficacious than anandamide as a CB" transporter, the anandamide amidohydrolase (fatty acid amide agonist, as assessed by measuring the stimulatory effect on intra- hydrolase, FAAH) and the two cannabinoid receptor subtypes, cellular Ca#+ mobilization in undifferentiated N18TG2 neuro- CB" and CB#. NADAs competitively inhibited FAAH from blastoma cells. This effect of AA-DA was counteracted by the l µ N18TG2 cells (IC&! 19–100 M), as well as the binding of the CB" antagonist SR141716A.
    [Show full text]
  • 2-Arachidonoylglycerol a Signaling Lipid with Manifold Actions in the Brain
    Progress in Lipid Research 71 (2018) 1–17 Contents lists available at ScienceDirect Progress in Lipid Research journal homepage: www.elsevier.com/locate/plipres Review 2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain T ⁎ Marc P. Baggelaara,1, Mauro Maccarroneb,c,2, Mario van der Stelta, ,2 a Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands. b Department of Medicine, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 21, 00128 Rome, Italy c European Centre for Brain Research/IRCCS Santa Lucia Foundation, via del Fosso del Fiorano 65, 00143 Rome, Italy ABSTRACT 2-Arachidonoylglycerol (2-AG) is a signaling lipid in the central nervous system that is a key regulator of neurotransmitter release. 2-AG is an endocannabinoid that activates the cannabinoid CB1 receptor. It is involved in a wide array of (patho)physiological functions, such as emotion, cognition, energy balance, pain sensation and neuroinflammation. In this review, we describe the biosynthetic and metabolic pathways of 2-AG and how chemical and genetic perturbation of these pathways has led to insight in the biological role of this signaling lipid. Finally, we discuss the potential therapeutic benefits of modulating 2-AG levels in the brain. 1. Introduction [24–26], locomotor activity [27,28], learning and memory [29,30], epileptogenesis [31], neuroprotection [32], pain sensation [33], mood 2-Arachidonoylglycerol (2-AG) is one of the most extensively stu- [34,35], stress and anxiety [36], addiction [37], and reward [38]. CB1 died monoacylglycerols. It acts as an important signal and as an in- receptor signaling is tightly regulated by biosynthetic and catabolic termediate in lipid metabolism [1,2].
    [Show full text]
  • A Dissertation Entitled Uncovering Cannabinoid Signaling in C. Elegans
    A Dissertation Entitled Uncovering Cannabinoid Signaling in C. elegans: A New Platform to Study the Effects of Medicinal Cannabis By Mitchell Duane Oakes Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Doctor of Philosophy Degree in Biology ________________________________________ Dr. Richard Komuniecki, Committee Chair _______________________________________ Dr. Bruce Bamber, Committee Member ________________________________________ Dr. Patricia Komuniecki, Committee Member ________________________________________ Dr. Robert Steven, Committee Member ________________________________________ Dr. Ajith Karunarathne, Committee Member ________________________________________ Dr. Jianyang Du, Committee Member ________________________________________ Dr. Amanda Bryant-Friedrich, Dean College of Graduate Studies The University of Toledo August 2018 Copyright 2018, Mitchell Duane Oakes This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of Uncovering Cannabinoid Signaling in C. elegans: A New Platform to Study the Effects of Medical Cannabis By Mitchell Duane Oakes Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Doctor of Philosophy Degree in Biology The University of Toledo August 2018 Cannabis or marijuana, a popular recreational drug, alters sensory perception and exerts a range of medicinal benefits. The present study demonstrates that C. elegans exposed to
    [Show full text]
  • Key Aspects to Consider About Beneficial and Harmful Effects on the Central Nervous System by the Endocannabinoid Modulation Linked to New Cardiovascular Therapies
    Review Article Annals of Pharmacology and Pharmaceutics Published: 03 Dec, 2019 Key Aspects to Consider about Beneficial and Harmful Effects on the Central Nervous System by the Endocannabinoid Modulation Linked to New Cardiovascular Therapies Martin Gimenez VM1, Mocayar Maron FJ2, Kassuha DE1, Ferder L3 and Manucha W4,5* 1Research in Chemical Sciences, Catholic University of Cuyo, Argentina 2Department of Morphophysiology, National University of Cuyo, Argentina 3Department of Pediatrics, University of Miami, USA 4Department of Pathology, National Council of Scientific and Technological Research (IMBECU-CONICET), Argentina 5Department of Pathology, National University of Cuyo, Mendoza, Argentina Abstract The endocannabinoid system is closely related to the central nervous system and exerts a promising therapeutic potential on it and other systems such as the cardiovascular, mainly through its neuromodulatory, neuroprotective and neuroinflammatory effects. For this reason, when designing new treatments for different relevant pathologies such as hypertension, it is necessary to take into account the side effects that such therapies can cause at the neurological level. Deeping knowledge of each cannabinoid and the molecular mechanisms that can lead to undesired results is necessary. The OPEN ACCESS present review analyzes the psychoactive consequences of anandamide and other similar substances *Correspondence: such as other endocannabinoids, phytocannabinoids and synthetic cannabinoids, to assess their Walter Manucha, Department of little-explored
    [Show full text]
  • SYNTHESIS of 3-HETEROCYCLE PHENYL N-ALKYL CARBAMATES and THEIR ACTIVITY AS FAAH INHIBITORS Doctoral Dissertation
    TKK Dissertations 203 Espoo 2009 SYNTHESIS OF 3-HETEROCYCLE PHENYL N-ALKYL CARBAMATES AND THEIR ACTIVITY AS FAAH INHIBITORS Doctoral Dissertation Mikko Myllymäki Helsinki University of Technology Faculty of Chemistry and Materials Sciences Department of Chemistry TKK Dissertations 203 Espoo 2009 SYNTHESIS OF 3-HETEROCYCLE PHENYL N-ALKYL CARBAMATES AND THEIR ACTIVITY AS FAAH INHIBITORS Doctoral Dissertation Mikko Myllymäki Dissertation for the degree of Doctor of Philosophy to be presented with due permission of the Faculty of Chemistry and Materials Sciences for public examination and debate in Auditorium KE2 (Komppa Auditorium) at Helsinki University of Technology (Espoo, Finland) on the 19th of December, 2009, at 12 noon. Helsinki University of Technology Faculty of Chemistry and Materials Sciences Department of Chemistry Teknillinen korkeakoulu Kemian ja materiaalitieteiden tiedekunta Kemian laitos Distribution: Helsinki University of Technology Faculty of Chemistry and Materials Sciences Department of Chemistry P.O. Box 6100 (Kemistintie 1) FI - 02015 TKK FINLAND URL: http://chemistry.tkk.fi/ Tel. +358-9-470 22527 Fax +358-9-470 22538 E-mail: [email protected] © 2009 Mikko Myllymäki ISBN 978-952-248-240-2 ISBN 978-952-248-241-9 (PDF) ISSN 1795-2239 ISSN 1795-4584 (PDF) URL: http://lib.tkk.fi/Diss/2009/isbn9789522482419/ TKK-DISS-2686 Multiprint Oy Espoo 2009 3 AB HELSINKI UNIVERSITY OF TECHNOLOGY ABSTRACT OF DOCTORAL DISSERTATION P.O. BOX 1000, FI-02015 TKK http://www.tkk.fi Author Mikko Juhani Myllymäki Name of the dissertation
    [Show full text]
  • N-Acyl Amino Acids (Elmiric Acids): Endogenous Signaling Molecules with Therapeutic Potential
    Molecular Pharmacology Fast Forward. Published on November 14, 2017 as DOI: 10.1124/mol.117.110841 This article has not been copyedited and formatted. The final version may differ from this version. MOL #110841 1 MINIREVIEW N-Acyl amino acids (Elmiric Acids): endogenous signaling molecules with therapeutic potential Sumner H. Burstein Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605 Downloaded from molpharm.aspetjournals.org at ASPET Journals on September 30, 2021 Molecular Pharmacology Fast Forward. Published on November 14, 2017 as DOI: 10.1124/mol.117.110841 This article has not been copyedited and formatted. The final version may differ from this version. MOL #110841 2 Running title. N-Acyl amino acids; endogenous signaling molecules Corresponding author: Sumner H. Burstein, Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605 [email protected] Phone: 508-856-2850 FAX: 508-856-2251 Number of of text pages, 26 Number of tables, 3 Downloaded from Number of figures, 4 Number of references, 60 Number of words in the: molpharm.aspetjournals.org Abstract, 220 Introduction, 742 Discussion, 6338 Abbreviations: COX, cyclooxygenase; FAAH, fatty acid amide hydrolase; GABA, γ- at ASPET Journals on September 30, 2021 aminobutyric acid; GPCR, G-protein coupled receptor; LXA4, lipoxin A4 ; LOX, 12,14 lipoxygenases; PGJ,15-deoxy-Δ -prostaglandin-J2 Molecular Pharmacology Fast Forward. Published on November 14, 2017 as DOI: 10.1124/mol.117.110841 This article has not been copyedited and formatted. The final version may differ from this version. MOL #110841 3 Abstract The subject of N-acyl amino acid conjugates has been rapidly growing in recent years, especially with regard to their analgesic and anti-inflammatory actions.
    [Show full text]
  • Roger G. Pertwee.Pdf
    Handbook of Experimental Pharmacology Volume 168 Editor-in-Chief K. Starke, Freiburg i. Br. Editorial Board G.V.R. Born, London M. Eichelbaum, Stuttgart D. Ganten, Berlin F. Hofmann, München B. Kobilka, Stanford, CA W. Rosenthal, B erlin G. Rubanyi, Richmond, CA Cannabinoids Contributors M.E.Abood,S.Bátkai,T.Bisogno,G.A.Cabral,M.J.Christie, A.A. Coutts, S.N. Davies, R. de Miguel, L. De Petrocellis, V. Di Marzo, M. Egertová, M.R. Elphick, J. Fernández-Ruiz, S.J. Gatley, S.T. Glaser, M. Gómez, S. Gonzáles, M. Guzmán, C.J. Hillard, W.-S.V. Ho, A.G. Hohmann, A.C. Howlett, M.A. Huestis, A.A. Izzo, M. Karsak, G. Kunos, C. Li, A.H. Lichtman, K.P. Lindsey, M. Maccarrone, K. Mackie, A. Makriyannis, B.R. Martin, S.P. Nikas, P. Pacher, R.G. Pertwee, J.A. Ramos, P.H. Reggio, G. Riedel, P. Robson, E. Schlicker, A. Staab, B. Szabo, G.A. Thakur, O. Valverde, C.W. Vaughan, J.M. Walker, T. Wenger, A. Zimmer Editor Roger G. Pertwee 123 Professor Dr. Roger Pertwee School of Medical Sciences Institute of Medical Science University of Aberdeen Foresterhill Aberdeen AB25 2ZD Scotland, UK email: [email protected] With 84 Figures and 26 Tables ISSN 0171-2004 ISBN 3-540-22565-X Springer Berlin Heidelberg New York Library of Congress Control Number: 2004109756 This work is subject to copyright. All rights reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broad- casting, reproduction on microfilm or in any other way, and storage in data banks.
    [Show full text]
  • A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
    Clinical and Translational Science Institute Centers 1-1-2018 The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain Giulia Donvito Virginia Commonwealth University Sara R. Nass West Virginia University Jenny L. Wilkerson Virginia Commonwealth University Zachary A. Curry Virginia Commonwealth University Lesley D. Schurman Virginia Commonwealth University See next page for additional authors Follow this and additional works at: https://researchrepository.wvu.edu/ctsi Part of the Medicine and Health Sciences Commons Digital Commons Citation Donvito, Giulia; Nass, Sara R.; Wilkerson, Jenny L.; Curry, Zachary A.; Schurman, Lesley D.; Kinsey, Steven G.; and Lichtman, Aron H., "The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain" (2018). Clinical and Translational Science Institute. 717. https://researchrepository.wvu.edu/ctsi/717 This Article is brought to you for free and open access by the Centers at The Research Repository @ WVU. It has been accepted for inclusion in Clinical and Translational Science Institute by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. Authors Giulia Donvito, Sara R. Nass, Jenny L. Wilkerson, Zachary A. Curry, Lesley D. Schurman, Steven G. Kinsey, and Aron H. Lichtman This article is available at The Research Repository @ WVU: https://researchrepository.wvu.edu/ctsi/717 Neuropsychopharmacology REVIEWS (2018) 43, 52–79 © 2018 American
    [Show full text]
  • The Endocannabinoid System As a Potential Therapeutic Target for Pain Modulation
    Copyright © Trakya University Faculty of Medicine Invited Review | 115 Balkan Med J 2014;31:115-20 © 2014 The Endocannabinoid System as a Potential Therapeutic Target for Pain Modulation Ahmet Ulugöl Department of Medical Pharmacology, Trakya University Faculty of Medicine, Edirne, Turkey Although cannabis has been used for pain management for millennia, on multi-target analgesia compounds, where one of the targets is the very few approved cannabinoids are indicated for the treatment of pain endocannabinoid degrading enzyme. In this review, I provide an over- and other medical symptoms. Cannabinoid therapy re-gained attention view of the current understanding about the processes accounting for only after the discovery of endocannabinoids and fatty acid amide hy- the biosynthesis, transport and metabolism of endocannabinoids, and pharmacological approaches and potential therapeutic applications in drolase (FAAH) and monoacylglycerol lipase (MAGL), the enzymes this area, regarding the use of drugs elevating endocannabinoid levels playing a role in endocannabinoid metabolism. Nowadays, research in pain conditions. (Balkan Med J 2014;31:115-20). has focused on the inhibition of these degradative enzymes and the Key Words: 2-AG, anandamide, endocannabinoids, FAAH, MAGL, elevation of endocannabinoid tonus locally; special emphasis is given pain Cannabinoids are a group of chemical compounds that pro- CANNABINOID RECEPTORS AND THE SITE OF duce their effects via activating cannabinoid receptors; they ACTION OF CANNABINOIDS include the phytocannabinoids (herbal cannabinoids/natural cannabinoids found in the cannabis plant), synthetic cannabi- To date, two subtypes of cannabinoid receptors, termed noids, and endogenous cannabinoids (endocannabinoids) (1, 2). cannabinoid-1 (CB1) and cannabinoid-2 (CB2) receptors, Cannabis, also known as marijuana, has been used as both a have been cloned (10, 11).
    [Show full text]
  • The Fatty Acid Amide Hydrolase (FAAH)
    Chemistry and Physics of Lipids 108 (2000) 107–121 www.elsevier.com/locate/chemphyslip Review The fatty acid amide hydrolase (FAAH) Natsuo Ueda a, Robyn A. Puffenbarger b, Shozo Yamamoto a, Dale G. Deutsch b,* a Department of Biochemistry, School of Medicine, Uni6ersity of Tokushima, Kuramoto-cho, Tokushima 770-8503, Japan b Department of Biochemistry and Cell Biology, State Uni6ersity of New York at Stony Brook, Stony Brook, NY 11794-5215, USA Received 3 May 2000; received in revised form 5 June 2000; accepted 5 June 2000 Abstract The topic of this review is fatty acid amide hydrolase (FAAH), one of the best-characterized enzymes involved in the hydrolysis of bioactive lipids such as anandamide, 2-arachidonoylglycerol (2-AG), and oleamide. Herein, we discuss the nomenclature, the various assays that have been developed, the relative activity of the various substrates and the reversibility of the enzyme reactions catalyzed by FAAH. We also describe the cloning of the enzyme from rat and subsequent cDNA isolation from mouse, human, and pig. The proteins and the mRNAs from different species are compared. Cloning the enzyme permitted the purification and characterization of recombinant FAAH. The conserved regions of FAAH are described in terms of sequence and function, including the amidase domain which contains the serine catalytic nucleophile, the hydrophobic domain important for self association, and the proline rich domain region, which may be important for subcellular localization. The distribution of FAAH in the major organs of the body is described as well as regional distribution in the brain and its correlation with cannabinoid receptors.
    [Show full text]